US 11492624
RNAi agents and compositions for inhibiting expression of Asialoglycoprotein receptor 1
granted A61KA61K9/0019
Quick answer
US patent 11492624 (RNAi agents and compositions for inhibiting expression of Asialoglycoprotein receptor 1) held by Arrowhead Pharmaceuticals, Inc. expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K9/0019